centogene is a worldwide leader in the field of genetic diagnostic testing for rare hereditary diseases, with a broad test portfolio covering over 2800 genes, biochemical tests, biomarker tests, clinical whole exome sequencing and whole genome sequencing. centogene’s mission is to support medical professionals with in-depth medical expertise in order to diagnose early the cause of the patients’ symptoms. analyzing samples from all over the world allows centogene to constantly expand its unique portfolio resulting in the largest systematic documentation of genetic results, centomd®. this mutation database integrates genetic and clinical information, enabling the highest quality, knowledge-based genetic testing and biomarker development. in addition to offering diagnostic services for individual patients, centogene is a pivotal partner to some of the most respected names in the industry. imprint centogene ag is a stock corporation ('aktiengesellschaft') incorporated under the